Skip to main content
Monique E. Cho
( out of 13 reviews )

Monique E. Cho, MD

Languages spoken: English, Korean

Clinical Locations

University of Utah Hospital

Kidney and Liver Clinic
801-581-2772
  • Moniqué E. Cho, M.D. is an Associate Professor in the Department of Medicine, Division of Nephrology & Hypertension. Dr. Cho received her B.A.degree in Psychology from Cornell University, NY and M.D. degree from Dartmouth Medical School, NH. She completed her Internal Medicine residency and Nephrology fellowship at the University of Rochester in New York. Dr. Cho's research interest focuses on the effects of metabolic complications of chronic kidney disease on the heart.

    Patient Rating

    5.0 /5
    ( out of 13 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    April 18, 2023
    UH HOSPITALS AND CLINICS

    Dr. Cho appeared to be a highly intelligent and experienced Nephrologist. Her approach to a new patient was comprehensive and detail oriented, yet well organized. She is a kind and caring physician with excellent bedside manner. I felt extremely lucky to have such an extraordinary doctor as my own.

    April 16, 2023
    UH HOSPITALS AND CLINICS

    Dr. Cho was the best medical provider I've ever had an appointment with. Her competence and capability are clear. However, I was moved by her thoughtful caring, questioning, listening, explaining, planning and moving forward with a clear path. Her use of research and application and understanding to me and my case was reassuring. I am truly impressed with her approach to medicine and her patients.

    April 16, 2023
    UH HOSPITALS AND CLINICS

    Very professional and very caring!

  • Moniqué E. Cho, M.D. is an Associate Professor in the Department of Medicine, Division of Nephrology & Hypertension. Dr. Cho received her B.A.degree in Psychology from Cornell University, NY and M.D. degree from Dartmouth Medical School, NH. She completed her Internal Medicine residency and Nephrology fellowship at the University of Rochester in New York. Dr. Cho's research interest focuses on the effects of metabolic complications of chronic kidney disease on the heart.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Nephrology

    Education history

    Professional Other Training Program in Clinical Research - National Institutes of Health/Duke University School of Medicine Senior Clinical Fellow
    Kidney Disease Branch - National Institute of Diabetes and Digestive and Kidney Diseases Senior Clinical Fellow
    Fellowship Nephrology - University of Rochester Medical Center Fellow
    Internal Medicine - University of Rochester Medical Center Resident
    Internship General Internal Medicine - Rhode Island Hospital Intern
    Medicine - Geisel School of Medicine at Dartmouth M.D.
    Graduate Training Harvard Extension School Postbaccalaureate Studies
    Psychology - Cornell University B.A.

    Selected Publications

    Journal Article

    1. Dolui S, Detre JA, Gaussoin SA, Herrick JS, Wang DJJ, Tamura MK, Cho ME, Haley WE, Launer LJ, Punzi HA, Rastogi A, Still CH, Weiner DE, Wright JT Jr, Williamson JD, Wright CB, Bryan RN, Bress AP, Pajewski NM, Nasrallah IM (2022). Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial. JAMA Neurol, 79(4), 380-389. (Read full article)
    2. Mehta RC, Cho ME, Cai X, Lee J, Chen J, He J, Flack J, Shafi T, Saraf SL, David V, Feldman HI, Isakova T, Wolf M, CRIC Study Investigators (2021). Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney disease. Kidney Int, 100(6), 1292-1302. (Read full article)
    3. Cho ME, Hansen JL, Peters CB, Cheung AK, Greene T, Sauer BC (2019). An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic Veterans with predialysis chronic kidney disease. Kidney Int, 96(3), 750-760. (Read full article)
    4. Agarwal A, Cheung AK, Ma J, Cho M, Li M (2019). Effect of Baseline Kidney Function on the Risk of Recurrent Stroke and on Effects of Intensive Blood Pressure Control in Patients With Previous Lacunar Stroke: A Post Hoc Analysis of the SPS3 Trial (Secondary Prevention of Small Subcortical Strokes). J Am Heart Assoc, 8(16), e013098. (Read full article)
    5. Upadhya B, Lovato LC, Rocco M, Lewis CE, Oparil S, Cushman WC, Kostis JB, Rodriguez CJ, Cho ME, Cloud LW, Rastogi A, Rosendorff C, Kitzman DW (2019). Heart failure prevention in older patients using intensive blood pressure reduction: Potential role of diuretics. JACC Heart Fail, 7(12), 1032-1041.
    6. Upadhya B, Rocco MV, Pajewski NM, Morgan T, Blackshear J, Hundley WG, Oparil S, Soliman EZ, Cohen DL, Hamilton CA, Cho ME, Kostis WJ, Papademetriou V, Rodriguez CJ, Raj DS, Townsend R, Vasu S, Zamanian S, Kitzman DW, SPRINT Research Group (2019). Effect of Intensive Blood Pressure Reduction on Left Ventricular Mass, Structure, Function, and Fibrosis in the SPRINT-HEART. Hypertension, HYPERTENSIONAHA11913073. (Read full article)
    7. Cho ME, Craven TE, Cheung AK, Glasser SP, Rahman M, Soliman EZ, Stafford RS, Johnson KC, Bates JT, Burgner A, Taylor AA, Tamariz L, Tang R, Beddhu S, SPRINT Study ResearchGroup (2017). The association between insulin resistance and atrial fibrillation: A cross-sectional analysis from SPRINT (Systolic Blood Pressure Intervention Trial). J Clin Hypertens (Greenwich), 19(11), 1152-1161. (Read full article)
    8. Soliman EZ, Ambrosius WT, Cushman WC, Zhang ZM, Bates JT, Neyra JA, Carson TY, Tamariz L, Ghazi L, Cho ME, Shapiro BP, He J, Fine LJ, Lewis CE, SPRINT Research Study Group (2017). Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial). Circulation, 136(5), 440-450. (Read full article)
    9. Chen X, Wei G, Jalili T, Metos J, Giri A, Cho ME, Boucher R, Greene T, Beddhu S (2016). The Associations of Plant Protein Intake With All-Cause Mortality in CKD. Am J Kidney Dis, 67(3), 423-30. (Read full article)
    10. Bhattacharyya N, Wiench M, Dumitrescu C, Connolly BM, Bugge TH, Patel HV, Gafni RI, Cherman N, Cho M, Hager GL, Collins MT (2012). Mechanism of FGF23 processing in fibrous dysplasia. J Bone Miner Res, 27(5), 1132-41. (Read full article)
    11. Chen X, Summers RM, Cho M, Bagci U, Yao J (2012). An automatic method for renal cortex segmentation on CT images: evaluation on kidney donors. Acad Radiol, 19(5), 562-70. (Read full article)
    12. Sharma K, Ix JH, Mathew AV, Cho M, Pflueger A, Dunn SR, Francos B, Sharma S, Falkner B, McGowan TA, Donohue M, Ramachandrarao S, Xu R, Fervenza FC, Kopp JB (2011). Pirfenidone for diabetic nephropathy. J Am Soc Nephrol, 22(6), 1144-51. (Read full article)
    13. Cho ME, Duan Z, Chamberlain CE, Reynolds JC, Ring MS, Mannon RB (2010). Cinacalcet improves bone density in post-kidney transplant hyperparathyroidism. Transplant Proc, 42(9), 3554-8. (Read full article)
    14. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Oleksyk T, McKenzie LM, Kajiyama H, Ahuja TS, Berns JS, Briggs W, Cho ME, Dart RA, Kimmel PL, Korbet SM, Michel DM, Mokrzycki MH, Schelling JR, Simon E, Trachtman H, Vlahov D, Winkler CA (2008). MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet, 40(10), 1175-84. (Read full article)
    15. Zhou H, Cheruvanky A, Hu X, Matsumoto T, Hiramatsu N, Cho ME, Berger A, Leelahavanichkul A, Doi K, Chawla LS, Illei GG, Kopp JB, Balow JE, Austin HA 3rd, Yuen PS, Star RA (2008). Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int, 74(5), 613-21. (Read full article)
    16. McKenzie LM, Hendrickson SL, Briggs WA, Dart RA, Korbet SM, Mokrzycki MH, Kimmel PL, Ahuja TS, Berns JS, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Cho M, Zhou YC, Binns-Roemer E, Kirk GD, Kopp JB, Winkler CA (2007). NPHS2 variation in sporadic focal segmental glomerulosclerosis. J Am Soc Nephrol, 18(11), 2987-95. (Read full article)
    17. Cho ME, Smith DC, Branton MH, Penzak SR, Kopp JB (2007). Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis. Clin J Am Soc Nephrol, 2(5), 906-13. (Read full article)
    18. Cho ME, Hurley JK, Kopp JB (2007). Sirolimus therapy of focal segmental glomerulosclerosis is associated with nephrotoxicity. Am J Kidney Dis, 49(2), 310-7. (Read full article)

    Review

    1. Cho ME, Beddhu S (2016). Dietary recommendations for patients with nondialysis CKD. [Review].
  • News & Podcasts